Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

about

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.

Item

http://www.wikidata.org/entity/Q37613070

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@en

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@nl

type

Item

label

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@en

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@nl

prefLabel

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@en

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@nl

P1476

Safety, Tolerability, and Phar ...... ompromised Pediatric Patients.

@en

P2093

Andreas H Groll

http://www.w3.org/2001/XMLSchema#string

Aziza T Shad

http://www.w3.org/2001/XMLSchema#string

Corina Gonzalez

http://www.w3.org/2001/XMLSchema#string

Donald Buell

http://www.w3.org/2001/XMLSchema#string

Ihor Bekersky

http://www.w3.org/2001/XMLSchema#string

Lauren V Wood

http://www.w3.org/2001/XMLSchema#string

Paul Jarosinski

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.

Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B.

In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?

Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.

P31

scholarly article

P356

10.1128/AAC.01477-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Hope

Nita L Seibel

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27855062

http://www.w3.org/2001/XMLSchema#string

P932

5278758

http://www.w3.org/2001/XMLSchema#string